bexarotene has been researched along with Huntington Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akimov, S; Arbez, N; Arreola, M; Dickey, AS; Evans, RM; Fan, W; Flores, AL; Gilmore-Hall, SK; Hsu, CL; La Spada, AR; Lo, DC; Lomas, N; Masliah, E; Nguyen, JM; Ohnishi, K; Ross, CA; Sampat, KR; Sanchez, DN; Van Kanegan, MJ | 1 |
1 other study(ies) available for bexarotene and Huntington Disease
Article | Year |
---|---|
PPARĪ“ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis.
Topics: Animals; Bexarotene; Gene Expression Regulation; Homeostasis; Humans; Huntington Disease; Mice; Muscle, Skeletal; Neurons; PPAR delta; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tetrahydronaphthalenes | 2017 |